Impact of Barostim on Heart Failure Hospitalization
Jacob Abraham, MD
Implementing the SOC Induction Therapies in AAV
Silke R. Brix, MD, MRCP, SCPR
Bernhard Hellmich, MD
Optimizing AAV Outcomes: Maintenance Therapies
Decoding ANCA-Associated Vasculitis (AAV): From Suspicion to Solution
Andreas Kronbichler, MD
Pearls of Wisdom: Optimizing Hyperkalemia Management in Patients with CKD
Matthew R. Weir, MD
Nihar Desai, MD
Ellie Kelepouris, MD, FACP, FAHA
Elevating Care for Patients With Severe Renal Disease in AAV
Preserving Renal Function in AAV: From Novel Therapies to Practice-Changing Strategies
June 06, 2025
Vienna
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Revolutionizing IgAN Care in the Era of Precision Medicine: Diagnostic Approaches, Evolving Guidelines, and Novel Therapies
June 05, 2025
Refining Strategies for Enhancing Cardiorenal Outcomes With SGLT2 Inhibitors: Optimizing the Cardiometabolic Care Model
Melissa Magwire, RN, MSN, CDE
Matthew Bullington, PharmD
Dawn M. Denicola, FNP-C
Keith Miller, MD
Unmasking IgAN: From Suspicion to Timely Diagnosis
Jörg Latus, MD
Chee Kay Cheung, MBCHB, MRCP, PHD
Finally, I Can Take a Break from My Itch! Optimizing CKD-aP Treatment
Advances in IgAN Care From Kidney Week
Sydney Tang, MBBS, MD
Cardiorenal Collaboration: Optimizing Multidisciplinary Care in the CvRM Patient
Raymond Townsend, MD
Michael Weber, MD
Partnering for Progress: A Case Study in Patient-Centered Hyperkalemia Management
David Wheeler, MB, CHB, MD, FRCP
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Christina Economides, MD
Brian Howard, MD
David N. Kenigsberg, MD, FACC